BSE Live
Feb 26, 16:01Prev. Close
175.50
Open Price
174.45
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Feb 26, 15:59Prev. Close
175.86
Open Price
176.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
176.81 (182)
| Cash Flow of Marksans Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 503.97 | 423.53 | 337.65 | 247.51 | 0.00 | |
| Net CashFlow From Operating Activities | 206.66 | 230.41 | 237.41 | 99.26 | 0.00 | |
| Net Cash Used In Investing Activities | -49.01 | -140.84 | -259.21 | -41.69 | 0.00 | |
| Net Cash Used From Financing Activities | -65.15 | -68.73 | 197.83 | 79.51 | 0.00 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 92.51 | 20.84 | 176.03 | 137.08 | 0.00 | |
| Cash And Cash Equivalents Begin of Year | 403.28 | 382.44 | 206.41 | 212.18 | 0.00 | |
| Cash And Cash Equivalents End Of Year | 495.79 | 403.28 | 382.44 | 349.27 | 0.00 |
10.02.2026
Marksans Pharma Consolidated December 2025 Net Sales at Rs 754.43 crore, up 10.64% Y-o-Y
09.02.2026
Buy Marksans Pharma; target of Rs 225: Choice Institutional Equities
09.02.2026
Marksans Pharma Standalone December 2025 Net Sales at Rs 339.73 crore, up 8.93% Y-o-Y
26.11.2025
Marksans Pharma Consolidated September 2025 Net Sales at Rs 720.41 crore, up 12.23% Y-o-Y
10.02.2026
Marksans Pharma Consolidated December 2025 Net Sales at Rs 754.43 crore, up 10.64% Y-o-Y
09.02.2026
Marksans Pharma Standalone December 2025 Net Sales at Rs 339.73 crore, up 8.93% Y-o-Y
26.11.2025
Marksans Pharma Consolidated September 2025 Net Sales at Rs 720.41 crore, up 12.23% Y-o-Y
24.11.2025
Marksans Pharma Standalone September 2025 Net Sales at Rs 320.44 crore, up 3.83% Y-o-Y